MTOR and amyotrophic lateral sclerosis: Enhancing autophagy using rapamycin to inhibit mammalian target of rapamycin (mTOR) was shown to worsen ALS related symptomology, decrease life span, and result in a more severe mitochondrial dysfunction, possibly activating apoptosis, in SOD1G93A mice (Zhang et al., 2011).